ICD 2021: Retreatment With Bimekizumab for Psoriasis Leads to Recapture of Response
Prior to retreatment, patients had been rerandomized to placebo, and then relapsed.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.